# Dexamethasone for Cardiac Surgery-II Trial

> **NCT03002259** · PHASE4 · UNKNOWN · sponsor: **Bayside Health** · enrollment: 1956 (actual)

## Conditions studied

- Inflammatory Response

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT03002259
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 1956 (ACTUAL)
- **Last updated:** 2023-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03002259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03002259, "Dexamethasone for Cardiac Surgery-II Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03002259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*